Primary progressive aphasia
Progressive language loss from brain tissue deterioration.
Primary progressive aphasia (PPA) is a neurological syndrome marked by a slow, steady decline in language abilities. Unlike other forms of aphasia, which often follow a sudden event like a stroke, PPA is caused by ongoing deterioration of brain tissue. This means early symptoms are much milder than later ones. The specific symptoms depend on which parts of the brain’s left hemisphere are damaged.
People with PPA gradually lose the ability to speak, write, read, and understand language. Eventually, nearly all patients become mute and cannot comprehend spoken or written language. While PPA was originally described as affecting only language while other mental functions stayed intact, it is now understood that many—if not most—patients also experience problems with memory, forming short-term memories, and executive functions.
PPA was first identified as a distinct syndrome by M. Marsel Mesulam in 1982. It clinically and pathologically overlaps with frontotemporal lobar degeneration (FTLD) disorders and Alzheimer’s disease. However, unlike those with Alzheimer’s, people with PPA generally remain able to take care of themselves.
**Causes** The specific causes of PPA and similar degenerative brain diseases are currently considered idiopathic (unknown). Autopsies of people who had PPA have revealed a variety of brain abnormalities, and imaging techniques like CT scans, MRI, EEG, SPECT, and PET scans show these abnormalities are almost always limited to the left hemisphere.
**Risk Factors** No large epidemiological studies have been done on how common PPA is, and its prevalence is likely underestimated. Onset typically occurs in a person’s 60s or 70s. No environmental risk factors are known, though one retrospective study suggested vasectomy might be a risk factor for men—a finding that has not been confirmed by prospective studies. PPA is not considered hereditary, but relatives of someone with any form of FTLD have a slightly higher risk of developing PPA or another FTLD disorder. About a quarter of PPA patients have a family history of PPA or another FTLD condition. Genetic predisposition varies by variant: progressive nonfluent aphasia (PNFA) is more often familial than semantic dementia (SD). The strongest genetic link found is a mutation in the GRN gene; most patients with this mutation show features of PNFA, though the presentation can be atypical.
**Dia
- field
- Neurology
- known_for
- Progressive language impairment with preserved self-sufficiency
- first_described_by
- M. Marsel Mesulam
- year_first_described
- 1982
- typical_onset
- Sixth or seventh decade
- genetic_mutation
- GRN gene
Quick Facts
- Field
- Neurology
Facts from the source article.
Lore & Background
Primary progressive aphasia is a type of neurological syndrome in which language capabilities slowly and progressively become impaired. As with other types of aphasia, symptoms depend on what parts of the brain's left hemisphere are significantly damaged. However, unlike most other aphasias, PPA results from continuous deterioration in brain tissue, which leads to early symptoms being far less detrimental than later symptoms. Those with PPA slowly lose the ability to speak, write, read, and generally comprehend language; eventually, almost every patient becomes mute and completely loses the ability to understand both written and spoken language. Although it was first described as solely impairment of language capabilities while other mental functions remain intact, it is now recognized that many, if not most, of those with PPA experience impairment of memory, short-term memory formation, and loss of executive functions.
Reader's Guide
Primary progressive aphasia is significant because it represents a distinct neurodegenerative syndrome that primarily targets language functions, unlike Alzheimer's disease where language decline is just one of many cognitive deteriorations. Its classification into three clinical variants—non-fluent (PNFA), semantic (SD), and logopenic (LPA)—allows for more precise diagnosis and understanding of underlying pathology. PPA has clinical and pathological overlap with frontotemporal lobar degeneration and Alzheimer's disease, yet patients with PPA generally maintain self-sufficiency, employment, and hobbies, distinguishing them from Alzheimer's patients. The condition's causes remain idiopathic, though genetic mutations in the GRN gene have been identified, and a family history of frontotemporal lobar degeneration slightly increases risk. Treatment is primarily behavioral, including speech therapy, as no drugs are specifically approved for PPA. The syndrome's progressive nature means improvement seldom occurs, unlike aphasias from brain trauma. Its legacy includes raising awareness of focal neurodegenerative disorders and the importance of language-specific neural networks.
Did You Know?
- PPA was first described as a distinct syndrome by M. Marsel Mesulam in 1982.
- Unlike Alzheimer's disease, people with PPA are generally able to maintain self-sufficiency.
- A mutation in the GRN gene is the most convincing genetic basis of PPA.
- There are no known environmental risk factors for progressive aphasias, though one retrospective study suggested vasectomy could be a risk factor in men.
More in Dementia 1-24
Spotted an error? Know more?
This is a living reference — every entry is fact-audited, and reader corrections feed straight into our audit queue. Suggest an edit · See this site's audit record